Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

FDA
News

Teva Received FDA Approval for Tasimelteon

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211601

byCharles Gross

December 13, 2022

1 minute read

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211601

Deutsche Bank Maintains Buy on Terex, Raises Price Target to $65

By Benzinga Newsdesk

Today, 10:34 PM

Deutsche Bank analyst Nicole Deblase maintains Terex (NYSE:TEX) with a Buy and raises the price target from $64 to $65.

TEX

B of A Securities Downgrades Rhythm Pharmaceuticals to Underperform, Lowers Price Target to $17

By Benzinga Newsdesk

Today, 10:34 PM

B of A Securities analyst Tazeen Ahmad downgrades Rhythm Pharmaceuticals (NASDAQ:RYTM) from Neutral to Underperform and lowers the price target from $33 to $17.

RYTM

Citigroup Initiates Coverage On DraftKings with Buy Rating, Announces Price Target of $66

By Benzinga Newsdesk

Today, 10:34 PM

Citigroup analyst Jason Bazinet initiates coverage on DraftKings (NASDAQ:DKNG) with a Buy rating and announces Price Target of $66.

DKNG

News

Germany’s Health Minister To Allow China’s Sinovac Vaccine To Be Used In Germany For Chinese Citizens

By Benzinga Newsdesk

Today, 10:34 PM

- Spiegel

EWG

Teva Received FDA Approval for Tasimelteon

Related Posts

Deutsche Bank Maintains Buy on Terex, Raises Price Target to $65

B of A Securities Downgrades Rhythm Pharmaceuticals to Underperform, Lowers Price Target to $17

Citigroup Initiates Coverage On DraftKings with Buy Rating, Announces Price Target of $66

Germany’s Health Minister To Allow China’s Sinovac Vaccine To Be Used In Germany For Chinese Citizens